JOIN OUR TEAM
The effects of COVID-19 continued to shift the chemicals & materials industry, with some markets benefiting from the pandemic and others still taking hits. We reported on those developments — in addition to conducting our market research reports and consulting projects — via an array of content in 2022. Here’s the most popular:
Join this webinar to learn about:
Specialty Excipients for Parenteral Pharmaceuticals is a market research program encompassing the consumption and supply of more than 40 specialty excipients used in parenteral formulations.
Biologics: The global pharmaceutical industry is facing a surge biologics. In recent years, biologic drugs have enjoyed a better approval rating than traditional drugs, as biologic drugs have been found to treat major chronic and complex diseases with higher safety and efficacy. The global production of biologics is expected to grow at a rate of
The global economy is experiencing severe turmoil for a host of reasons; including the massive drop in the price of oil, the slowdown in growth in China, the concerns about lending and real estate bubbles in China, the economic and financial struggles in Europe, emerging economy travails, and geopolitical challenges in the Middle East.
Kline, a respected provider of world-class consulting services and high-quality market intelligence, today announced recent additions to the company’s executive team. Kline is proud to announce the appointments of Annie Jarquin as Director in the Energy Practice and Hardeep Parmar as Director in the Chemicals Practice of Kline’s Management Consulting business. Their respective experience will
The markets for HI&I ingredients in the United States, China, and India—the three regions from the upcoming global HI&I ingredients report—are rather diverse in terms of growth, value, and volume. While there are differences in the size of these markets and their growth potentials, qualitative attributes also differ widely. The consumption of ingredients in all
With approximately 90% of the active pharmaceutical ingredients that are under development falling into the two low solubility classes of the Biopharmaceutical Classification System (BCS), solubility enhancement technologies represent a strongly growing need for the pharmaceutical industry globally. Our current research covering solubility enhancement technologies and the related excipients market forecasts a compound annual growth
Poor solubility has been a major challenge in the formulation development for oral solid dosage form (OSDF) pharmaceuticals, a preferred route for pharmaceutical consumption. Various methods have been researched to improve solubility of poorly soluble API and among these the use of polymers for solubility enhancement in solid dispersions is among the most popular. Identifying
Complex combination of factors are driving the market of specialty excipients for OSDF globally On a global scale, the oral solid dosage form (OSDF) excipients market is growing sustainably, historically exhibiting a robust increase. This market is valued at nearly $2.3 billion in the United States, Europe, India, and China, according to recently published Specialty
